Serologically positive gastric cancers associated with Epstein-Barr virus

2021 ◽  
Vol 24 (3) ◽  
pp. 77
Author(s):  
I.I. Alentov ◽  
A.V. Chaika ◽  
V.Yu. Skoropad ◽  
V.M. Khomyakov ◽  
S.S. Pirogov ◽  
...  
2017 ◽  
Vol 25 (9) ◽  
pp. 609-614 ◽  
Author(s):  
Cigdem Irkkan ◽  
Serdar Balci ◽  
Gaye Güler Tezel ◽  
Bülent Akinci ◽  
Bülent Yalcin ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 4052-4052 ◽  
Author(s):  
Sarah Derks ◽  
Xiaoyun Liao ◽  
Xinsen Xu ◽  
M. Constanza Camargo ◽  
Anna M Chiaravalli ◽  
...  

2011 ◽  
Vol 71 (23) ◽  
pp. 7187-7197 ◽  
Author(s):  
Keisuke Matsusaka ◽  
Atsushi Kaneda ◽  
Genta Nagae ◽  
Tetsuo Ushiku ◽  
Yasuko Kikuchi ◽  
...  

2001 ◽  
Vol 197 (6) ◽  
pp. 395-400 ◽  
Author(s):  
Mee Soo Chang ◽  
Hye Seung Lee ◽  
Chul Woo Kim ◽  
Yong Il Kim ◽  
Woo Ho Kim

2020 ◽  
Vol 9 (5) ◽  
pp. 1427 ◽  
Author(s):  
Maria Grazia Rodriquenz ◽  
Giandomenico Roviello ◽  
Alberto D’Angelo ◽  
Daniele Lavacchi ◽  
Franco Roviello ◽  
...  

Gastric cancers have been historically classified based on histomorphologic features. The Cancer Genome Atlas network reported the comprehensive identification of genetic alterations associated with gastric cancer, identifying four distinct subtypes— Epstein-Barr virus (EBV)-positive, microsatellite-unstable/instability (MSI), genomically stable and chromosomal instability. In particular, EBV-positive and MSI gastric cancers seem responsive to novel immunotherapies drugs. The aim of this review is to describe MSI and EBV positive gastric cancer’s subgroups and their relationship with novel immunotherapy.


2018 ◽  
Vol 9 ◽  
Author(s):  
Iva Polakovicova ◽  
Sofia Jerez ◽  
Ignacio A. Wichmann ◽  
Alejandra Sandoval-Bórquez ◽  
Nicolás Carrasco-Véliz ◽  
...  

Oncotarget ◽  
2016 ◽  
Vol 7 (22) ◽  
pp. 32925-32932 ◽  
Author(s):  
Sarah Derks ◽  
Xiaoyun Liao ◽  
Anna M. Chiaravalli ◽  
Xinsen Xu ◽  
M. Constanza Camargo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document